AKT1 and Parkinson disease: Additionally, baicalin mitigated 6-OHDA-induced cell damage and exerted therapeutic effects on PD by downregulating miR-192-5p and suppressing the PI3K/Akt1 and Mdm2/Tp53 signaling pathways [82] (Figure 3).